A half of domestic M&A cases are made between pharmaceutical companies

Published: 2015-04-17 13:54:25

Updated: 2015-04-17 13:54:25

It is observed that M&As among pharmaceutical companies are more active than other industries.

The Korea Health Industry Development Institute analyzed M&A cases of global pharmaceutical companies between 2010 and 2014, and reported the result through a report titled the ‘Current State and Strategic Implications in M&A among Global Pharmaceutical Companies.’

According to the report analyzing ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.